Myasthenia gravis (MG) is the most frequent neuromuscular transmission disorder with incidence of 2-20 patients per million. Its pathophysiology is autoimmune, with acetylcholine receptors (AChR) autoantibodies damaging the post-synaptic fold at the muscle membrane. MG often presents with isolated ocular symptoms, including diplopia and ptosis, at least at the onset. Even in patients with generalized symptoms, ocular signs occur in almost all patients in some point during the course of the disease. In up to 15% of the patients the disease remains confined to the eyes 1 . Other clinical features include bulbar symptoms (dysphagia, dysarthria), proximal limb muscles weakness and fatigue. Unusual presentations as distal limb muscles weakness can also be found in a minority of cases 2,3 . The main characteristic of the MG is the fluctuating weakness during the day, being milder during the morning and more severe at the evening. Physical activity usually worsens the weakness. The diagnostic confirmation of MG is often challenging. The tests usually performed to confirm the diagnosis of MG are the edrophonium test (Tensilon®), repetitive nerve stimulation (RNS), single fiber EMG and serum acetilcholine receptors (AchR) antibodies. The most traditional bedside diagnostic test for myasthenia gravis is the edrophonium test. It has been considered diagnostic of MG in the past, however false-positive results have been reported in other neurologic disorders like amyotrophic lateral sclerosis, botulism and brain tumor 4,5 . Furthermore, it carries a risk of serious cardiac adverse reations. Its sensitivity is about 86% in pure ocular disease 6 . Unfortunately it is not easily available in Brazil. Another bedside test that can be done is the sleep test, however this test is time consuming and probably not practical for the busy physician, since the patient has to take a nap of 15 to 20 minutes in a dark room for clinical comparison 7 . The other complementary tests have variable sensitivity and specificity. The diagnostic field of the RNS and AchR antibodies for pure ocular disease is quite low. The AChR antibodies are the most specific test for myasthenia gravis, however the sensitivity varies from 56% in pure ocular myasthenia according to Tabassi et al. 8 to 70% in Oh et al. 9 study. The repetitive nerve stimulation has even lesser sensitivity, varying from 35% in distal muscles to 45% in proximal muscles 10 . The most sensitive test for ocular myasthenia is single fiber EMG, reaching up to 80% in pure ocular cases and 95% in generalized disease 9 , however its specificity is low, the test is expensive, technically demanding and not widely available.The ice pack test is a very simple, safe and cheap procedure that can be performed by the physician at the bedside 10 . Moreover, the ice pack test does not require medications or expensive equipment and is free of adverse effects 11 . It consists of the application of an ice pack on the patient symptomatic eye for 3 to 5 minutes. The response is positive when there is improv...